![](/img/cover-not-exists.png)
N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington's Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial
Reilmann, R., Squitieri, F., Priller, J., Saft, C., Mariotti, C., Sussmuth, S., Nemeth, A., Tabrizi, S., Quarrell, O., Craufurd, D., Rickards, H., Rosser, A., Darpo, B., Tessari, M., Szynol, A., FischVolume:
85
Language:
english
Journal:
Journal of Neurology, Neurosurgery & Psychiatry
DOI:
10.1136/jnnp-2014-309032.294
Date:
September, 2014
File:
PDF, 69 KB
english, 2014